Pear Therapeutics- Warrants (01/12/2026) Current Cash

As of the most recent data (December 2022), PEARW shows a current cash of $48M. That compares with $170M in the prior-year period — down 71.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PEARW's current cash is now $48M (was $170M) — a 71.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pear Therapeutics- Warrants (01/12/2026) is outperforming or lagging.

Tracking PEARW's current cash over time shows whether Pear Therapeutics- Warrants (01/12/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $48M That compares with $170M in the prior-year period — down 71.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Pear Therapeutics- Warrants (01/12/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $48M) with ownership activity and broader fundamentals.